Event-Driven Stocks

Odyssey Therapeutics, Inc.

ODTXNasdaq

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗

Financials

SEC XBRL · annual

No structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).

Clinical trials

ClinicalTrials.gov · ongoing · next readout first

Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
7 acquisitions0 disposals3 open-market buy(s)net +4.3M shares · last 7
InsiderDateTypeSharesPrice
Tpg Gp A, LlcMay 11, 2026J423,111—
Dimension Capital Ii, L.P.DirectorMay 8, 2026Conversion1.7M—
Sr One Capital Management, Llc10% ownerMay 11, 2026Conversion474,048—
Leiden Jeffrey MDirectorMay 8, 2026Buy5,000$20.00
Haas JasonOfficer — Chief Financial OfficerMay 8, 2026Buy1,000$20.00
Li Nan (Ln)DirectorMay 11, 2026Conversion1.7M—
Chu ShelleyDirectorMay 11, 2026Buy11,111$18.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202686,5031.0+100.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)